Skip to content

46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227

Published: July 22, 2026Updated: August 27, 2026

A condition where an XX individual has excess male hormones causing atypical genital development. It affects both newborns and older individuals. Treatment may involve hormone management and surgical options.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
N50.9
ICD-11
GA00.0
Body system
reproductive
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Ambiguous genitalia at birth

External genitalia that appears neither typically male nor typically female, with partially fused labial-scrotal folds and enlarged phallic structure.

Immediately at birth for urgent specialist evaluation and appropriate gender assignment counseling.

Clitoromegaly

(reproductive)

Abnormally enlarged clitoris due to prenatal androgen exposure, varying in severity from mild to significant enlargement.

Frequency: 85-95% of patients

Labial fusion

(reproductive)

Partial or complete fusion of the labia minora or majora, creating a scrotal-like appearance.

Frequency: 70-80% of patients

Hirsutism

(dermatologic)

Excess growth of coarse hair in male-pattern distribution, including face, chest, and back.

Frequency: 60-75% of patients

Severe neonatal acne

(dermatologic)

Inflammatory acne presenting shortly after birth due to transplacental androgen exposure.

Frequency: 50-70% of patients

Accelerated growth velocity

(endocrine)

Faster than normal growth rate in childhood due to early bone maturation from androgen exposure.

Frequency: 55-70% of patients

Premature pubarche

(endocrine)

Early development of pubic hair before age 8, indicating early adrenarche from androgen excess.

Frequency: 50-65% of patients

Deepening of voice

(respiratory)

Lower-pitched voice developing in childhood due to vocal cord thickening from androgen effects.

Frequency: 25-35% of patients

Primary amenorrhea

(reproductive)

Absence of menstruation by age 15 or 3 years after secondary sexual characteristics develop.

Frequency: Variable, depends on virilization severity

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anti-Androgen Therapy

Medications such as spironolactone or other anti-androgen agents to block excess androgen effects. Used to manage hirsutism, acne, and other androgen-mediated symptoms.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Oral Contraceptive Pills

Combined hormonal contraceptives to suppress ovarian androgen production and regulate menstrual cycles. Provides predictable bleeding and reduces androgen effects.

medication

Additional treatment options

Cosmetic Hair Management

Long-term hair removal strategies including laser therapy, electrolysis, or temporary methods. Addresses psychosocial impact of hirsutism and improves quality of life.

lifestyle

Body Image and Self-Esteem Support

Therapeutic support addressing body image concerns, anxiety, and depression associated with visible androgen effects. May include cognitive behavioral approaches.

psychological

Cosmetic Procedures

Dermatological procedures for acne scarring, skin texture improvement, or other cosmetic concerns related to androgen excess effects.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Speiser PW, Arlt W, Auchus RJ, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism. 2018.

guideline2018View source →
2

Lee PA, Houk CP, Ahmed SF, Hughes IA. Consensus statement on management of intersex disorders. Pediatrics. 2006.

consensus2006View source →
3

Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. Archives of Disease in Childhood. 2006.

consensus2006View source →
4

Witchel SF, Azziz R. Congenital adrenal hyperplasia. Journal of Pediatric and Adolescent Gynecology. 2011.

review2011View source →
5

American Academy of Pediatrics. Technical report: Disorders of sex development. Pediatrics. 2008.

position_statement2008View source →
6

Miller WL, Merke DP. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. New England Journal of Medicine. 2020.

review2020View source →
7

Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ. Williams Textbook of Endocrinology. 14th ed. Elsevier. 2020.

textbook2020
8

Mieszczak J, Houk CP, Lee PA. Disorders of sex development: Current perspectives. Current Opinion in Endocrinology, Diabetes and Obesity. 2009.

review2009View source →
9

WHO. ICD-11 for Mortality and Morbidity Statistics: 6D50. Congenital adrenal hyperplasia. World Health Organization. 2022.

10

Khatchadourian K, Migeon CJ, Brown GA. Congenital adrenal hyperplasia. Expert Review of Endocrinology & Metabolism. 2011.

review2011View source →

Medication Comparisons

Compare medications used to treat 46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy